Visualization analysis of research literature on TCM regulation of tumor microenvironment
-
摘要:
目的 肿瘤微环境是肿瘤领域的重点问题。本研究通过可视化方法系统分析中医药调节肿瘤微环境的研究现状和热点,旨在揭示其主要机制和临床应用。 方法 在中国知识资源总库(CNKI)、中国学术期刊数据库(万方数据)、中文科技期刊数据库(VIP)、中国生物医学文献数据库(CBM)、Web of Science(WOS)分别进行文献检索,时间设置为建库至2024年3月22日。应用NoteExpress进行文献筛选,使用GraphPad Prism绘制每年发文量计量分析图;采用VOSviewer对作者、关键词进行分析,绘制作者共现网络、关键词时间网络;利用CiteSpace进行关键词聚类分析。 结果 最终纳入690篇文献。首篇研究自2005年出现,2018年后发文量呈现快速上升趋势。发文量较多的期刊有《中华中医药杂志》《中医杂志》《中国实验方剂学杂志》《Journal of Ethnopharmacology》《Fronyiers in Pharmacology》等。中文文章共涉及作者1 766人。英文文章共涉及作者1 443人。得到中文关键词聚类9个、英文关键词聚类11个,主要包括作用机制和临床应用领域。 结论 通过可视化分析,研究发现中医药通过影响肿瘤血管生成、炎症、外泌体、细胞自噬与凋亡、巨噬细胞极化等机制调控肿瘤微环境,目前广泛应用于乳腺癌、肺癌、肝癌、结直肠癌、胃癌等癌种。 Abstract:Objective The tumor microenvironment has been a critical focus in cancer research. This study employs visualization methods to systematically analyze the current research landscape and highlight key areas of interest concerning the regulation of the tumor microenvironment by traditional Chinese medicine. The objective is to elucidate its primary mechanisms and clinical applications. Methods A comprehensive literature search was conducted across various databases including CNKI, Wanfang Data, VIP, CBM, and WOS, with the search period ending on March 22, 2024. NoteExpress was used for literature screening, GraphPad Prism was employed to chart annual publication trends, VOSviewer was used for analyzing authors and keywords and creating author co-occurrence networks and keyword time networks, and CiteSpace was used for keyword clustering analysis. Results A total of 690 documents were included in the study. The earliest publication was recorded in 2005, with a significant increase in publications observed since 2018. High-frequency publishing journals include 'China Journal of Traditional Chinese Medicine and Pharmacy', 'Journal of Traditional Chinese Medicine', 'Chinese Journal of Experimental Traditional Medical Formulas', 'Journal of Ethnopharmacology', and 'Fronyiers in Pharmacology'. The Chinese-language publications included a total of 1 766 authors, while English-language publication included a total of 1 443 authors. A total of 9 Chinese and 11 English keyword clusters were identified, with major themes centering on mechanisms of action and clinical applications. Conclusion Visual analysis found that TCM regulates the tumor microenvironment by pathways including tumor angiogenesis, inflammation, exosomes, autophagy, apoptosis, and macrophage polarization. TCM has been widely applied in the treatment of various cancer types, including breast, lung, liver, colorectal, and gastric cancers. -
Key words:
- Traditional Chinese medicine /
- Tumor microenvironment /
- Visual analysis /
- Bibliometrics /
- VOSviewer /
- CiteSpace
-
表 1 中医药调节肿瘤微环境相关中文文献来源期刊(≥10篇)
Table 1. Chinese literature search strategy on the regulation of the tumor microenvironment by traditional Chinese medicine (retrieved ≥10 relevant articles)
来源期刊 发表数量(%) 中华中医药杂志 31(6.62) 中医杂志 23(4.91) 中国实验方剂学杂志 22(4.70) 时珍国医国药 12(2.56) 中国中医基础医学杂志 11(2.35) 世界中医药 10(2.14) 表 2 中医药调节肿瘤微环境相关英文文献来源期刊(≥5篇)
Table 2. English literature search strategy on traditional Chinese medicine regulation of the tumor microenvironment (yielding ≥5 relevant articles)
来源期刊 发表数量(%) Journal of Ethnopharmacology 21(9.46) Frontiers in Pharmacology 18(8.11) Evidence-based Complementary and Alternative Medicine 12(5.41) Phytomedicine 10(4.50) Chinese Journal of Integrative Medicine 9(4.05) 表 3 中英文文献高频关键词(前15位)
Table 3. Most frequent keywords in Chinese and English literature (Top 15)
关键词 共现次数 关键词 共现次数 肿瘤微环境 190 tumor microenvironment 47 肿瘤 59 expression 42 微环境 38 cancer 41 中医药 34 cells 41 乳腺癌 32 apoptosis 33 肝癌 27 Traditional Chinese Medicine 33 免疫微环境 23 metastasis 25 肺癌 23 activation 22 胃癌 21 growth 20 肿瘤相关巨噬细胞 19 inflammation 20 结直肠癌 17 colorectal cancer 19 肿瘤免疫微环境 14 macrophages 18 小鼠 13 therapy 17 癌毒 13 epithelial-mesenchymal transition 14 网络药理学 13 proliferation 14 -
[1] XIAO Y, YU D. Tumor microenvironment as a therapeutic target in cancer[J]. Pharmacol Ther, 2021, 221: 107753. DOI: 10.1016/j.pharmthera.2020.107753. [2] JIN M Z, JIN W L. The updated landscape of tumor microenvironment and drug repurposing[J]. Signal Transduct Target Ther, 2020, 5(1): 166. DOI: 10.1038/s41392-020-00280-x. [3] ARRUDA H, SILVA E R, LESSA M, et al. VOSviewer and Bibliometrix[J]. J Med Libr Assoc, 2022, 110(3): 392-395. doi: 10.5195/jmla.2022.1434 [4] 赵琦瑶, 李皎月, 温雅璐, 等. 基于CiteSpace的中医药治疗糖尿病心肌病可视化分析[J]. 中华全科医学, 2023, 21(12): 2064-2067, 2155. doi: 10.16766/j.cnki.issn.1674-4152.003291ZHAO Q Y, LI J Y, WEN Y L, et al. Visual analysis of traditional Chinese medicine in the treatment of diabetic cardiomyopathy based on CiteSpace[J]. Chinese Journal of General Practice, 2023, 21(12): 2064-2067, 2155. doi: 10.16766/j.cnki.issn.1674-4152.003291 [5] 于艺, 朱征, 李艳伟, 等. 文献计量视域下人工智能在针灸领域应用的研究现状及展望[J]. 中国针灸, 2024, 44(8): 975-982.YU Y, ZHU Z, LI Y W, et al. Research status and prospect of the application of artificial intelligence in the acupuncture and moxibustion field based on bibliometric[J]. Chinese Acupuncture & Moxibustion, 2024, 44(8): 975-982. [6] 康焱红, 王金星, 方芳, 等. 2012—2022年补阳还五汤研究文献可视化分析[J]. 中国中医药信息杂志, 2023, 30(8): 50-55.KANG Y H, WANG J X, FANG F, et al. Visual analysis on research literature on Buyanghuanwu decoction from 2012 to 2022[J]. Chinese Journal of Information on Traditional Chinese Medicine, 2023, 30(8): 50-55. [7] 夏青青, 陈偶英, 曾勇, 等. 吴茱萸汤研究热点及趋势可视化分析[J]. 中国中医药信息杂志, 2024, 31(2): 84-89.XIA Q Q, CHEN O Y, ZENG Y, et al. Visual analysis on research hotspots and trends of Wuzhuyu decoction[J]. Chinese Journal of Information on Traditional Chinese Medicine, 2024, 31(2): 84-89. [8] LV B, WANG Y, MA D, et al. Immunotherapy: reshape the tumor immune microenvironment[J]. Front Immunol, 2022, 13: 844142. DOI: 10.3389/fimmu.2022.844142. [9] 张阳, 杨丽娜, 李玉洁, 等. 基于肿瘤微环境调节抗肿瘤转移的药理学研究进展[J]. 中国实验方剂学杂志, 2024, 30(13): 209-218.ZHANG Y, YANG L N, LI Y J, et al. Anti-metastatic pharmacology based on tumor microenvironment regulation: a review[J]. Chin J Exp Tradit Med Formulae, 2024, 30(13): 209-218. [10] 王玉如, 李慧杰, 刘寨东. 基于肿瘤微环境探讨癌性疼痛络病病机的生物学基础[J]. 安徽中医药大学学报, 2024, 43(1): 9-12.WANG Y R, LI H J, LIU Z D. To explore the biological basis of pathogenesis of cancer pain collateral disease based on tumor microenvironment[J]. Journal of Anhui University of Chinese Medicine, 2024, 43(1): 9-12. [11] 贺佳文, 韩冰, 卢佳萱, 等. 从肿瘤微环境的重塑探索扶正解毒法治疗肿瘤的机制[J]. 环球中医药, 2024, 17(2): 273-276.HE J W, HAN B, LU J X, et al. To explore the mechanism of Fuzhengjiedu method in the treatment of tumor from the remodeling of tumor microenvironment[J]. Global Traditional Chinese Medicine, 2024, 17(2): 273-276. [12] 呼宇, 曹寒冰, 龚政艳, 等. 肿瘤微环境中免疫细胞自身调控及中药成分对其调控的研究进展[J]. 西北药学杂志, 2024, 39(1): 211-220.HU Y, CAO H B, GONG Z Y, et al. Research progress of self-regulation and the regulation by Chinese herbal ingredients of immune cells in tumor microenvironment[J]. Northwest Pharmaceutical Journal, 2024, 39(1): 211-220. [13] 毛琼, 杨锦平, 张现明, 等. 金刚藤胶囊治疗宫内节育器致生殖系统炎症的疗效及对辅助性T细胞因子的影响[J]. 中国民间疗法, 2023, 31(3): 57-60.MAO Q, YANG JP, ZHANG XM, et al. Effect of Jingangteng capsule on reproductive system inflammation caused by intrauterine device and its influence on T helper cytokines[J]. China' s Naturopathy, 2023, 31(3): 57-60. [14] ZONG S, LI X, ZHANG G, et al. Effect of luteolin on glioblastoma' s immune microenvironment and tumor growth suppression[J]. Phytomedicine, 2024, 130: 155611. DOI: 10.1016/j.phymed.2024.155611. [15] 朱燃培, 李小青, 张华, 等. 大黄虫丸治疗肝癌的研究进展[J]. 中华中医药学刊, 2024, 42(1): 166-173.ZHU R P, LI X Q, ZHANG H, et al. Research progress on treatment of liver cancer with Dahuangzhechong pill[J]. Chinese Archives of Traditional Chinese, 2024, 42(1): 166-173. [16] IRANZADEH S, DALIL D, KOHANSAL S, et al. Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies[J]. J Pharm Pharmacol, 2024, 76(8): 967-982. doi: 10.1093/jpp/rgae041 [17] 李潇, 于泓洋, 田培裕, 等. 黄芪-莪术对Lewis肺癌小鼠肿瘤血管及肿瘤微环境中CD8+T细胞的影响[J]. 世界中西医结合杂志, 2023, 18(5): 929-938.LI X, YU H Y, TIAN P Y, et al. Effect of radix astragali seu hedysari-rhizoma curcumae on tumor vasculatures and CD8+ T Cells in tumor microenvironments of mice with Lewis lung cancer[J]. World J Integr Tradit West Med, 2023, 18(5): 929-938. [18] 陈进宝, 贾琳琳, 汪红平, 等. 基于肿瘤微环境探讨六神丸对结肠癌小鼠移植瘤的抗肿瘤作用[J]. 肿瘤防治研究, 2022, 49(12): 1212-1216.CHEN J B, JIA L L, WANG H P, et al. Antitumor effect of Liu-Shen-Wan on transplanted tumors of mice with colon cancer from perspective of tumor microenvironment[J]. Cancer Research on Prevention and Treatment, 2022, 49(12): 1212-1216. [19] 董星宇, 朱婷, 李白坤, 等. 华蟾素对肝癌炎症微环境中HUVEC血管生成的调控作用[J]. 中国药理学通报, 2022, 38(3): 354-359.DONG X Y, ZHU T, LI B K, et al. Regulative effect of cinobufocini on HUVEC angiogenesis in inflammatory microenvironment of liver cancer[J]. Chin Pharmacol Bull, 2022, 38(3): 354-359. [20] 何彦丽, 应逸, 许艳丽, 等. 枸杞多糖对荷瘤小鼠肿瘤微环境T淋巴细胞亚群及树突状细胞的影响[J]. 中西医结合学报, 2005(5): 44-47.HE Y L, YING Y, XU Y L, et al. Effects of Lycium barbarum polysaccharide on tumor microenvironment T-lymphocyte subsets and dendritic cells in H22-bearing mice[J]. Journal of Integrative Medicine, 2005(5): 44-47. [21] 熊露, 田少霞. 扶正培本治则方药调节肿瘤微环境免疫与血管正常化的思路研究[J]. 中国中西医结合杂志, 2010, 30(2): 201-204.XIONG L, TIAN S X. A Concept of regulating tumor microenvironment immune and normalizing angiogenesis by chinese medicine drug therapy for supporting zheng-qi to prop up root[J]. Chin J Integr Tradit West Med, 2010, 30(2): 201-204. [22] PITTERI S J, KELLY-SPRATT K S, GURLEY K E, et al. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression[J]. Cancer Research, 2011, 71(15): 5090-5100. doi: 10.1158/0008-5472.CAN-11-0568 [23] 胡康蝶, 杨凯歌, CHEDDAH S, 等. 基于蛋白质组学的黄芪多糖对TLR4激活的肺癌细胞来源外泌体的作用研究[J]. 中国中药杂志, 2022, 47(21): 5908-5915.HU K D, YANG K G, CHEDDAH S, et al. Proteomics analysis of astragalus polysaccharide on TLR4-activated lung cancer cell-derived exosomes[J]. China Journal of Chinese Materia Medica, 2022, 47(21): 5908-5915. [24] 钱晶晶, 魏娟, 孟桂霞, 等. 灵芝多糖微乳诱导结直肠癌肿瘤相关巨噬细胞M1极化及其联合PD-1抑制剂协同抗肿瘤研究[J]. 中国医院药学杂志, 2023, 43(3): 278-284.QIAN J J, WEI J, MENG G X, et al. M1 Ganoderma lucidum polysaccharide microemulsion induces M1 repolarization of colorectal cancer-associated macrophages and combined synergistic anti-tumor therapy with PD-1 inhibitor[J]. Chinese Journal of Hospital Pharmacy, 2023, 43(3): 278-284. [25] 商泽斌, 邱琬婷, 凌燕筠, 等. 基于网络药理学与生物信息学揭示冬凌草调控乳腺癌能量代谢的作用及分子机制[J]. 中国现代应用药学, 2023, 40(11): 1441-1453.SHANG Z B, QIU W T, LING Y J, et al. Uncovering the effect and molecular mechanism of rabdosia rubescens in regulating energy metabolism in breast cancer based on network pharmacology and bioinformatics[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(11): 1441-1453. [26] 王萍, 李锦超, 任美玲, 等. 乌梅丸对乳腺癌小鼠原位瘤微环境基因表达谱及免疫相关基因表达的影响[J]. 中华中医药杂志, 2024, 39(2): 913-920.WANG P, LI J C, REN M L, et al. Effects of Wumei Pills on gene microenvironment expression profile and immune related gene expression in orthotopic tumor of breast cancer mice[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2024, 39(2): 913-920. [27] 许春景, 郭旭, 陈杰, 等. 铜死亡相关lncRNA预测三阴性乳腺癌患者预后及与肿瘤免疫微环境的关系[J]. 浙江医学, 2023, 45(23): 2468-2472, 2508.XU C J, GUO X, CHEN J, et al. Cuproptosis-related lncRNA predict the prognosis of patients with triple-negative breast cancer and their relationship with tumor immune microenvironment[J]. Zhejiang Medical J, 2023, 45(23): 2468-2472, 2508. -
下载: